The cannabis industry is indeed blossoming, and with legalization underway in the US, the industry will only get even better. The sector requires all sorts of support to continue growing and such aim is what KushCo Holdings Inc (OTCMKTS: KSHB) offers.
KushCo Holdings markets, sells as well as distributes packaging products and solutions such as bags, bottles, containers, and tubes for the marijuana industry in South America, Europe, and North America. Moreover, it oversees more than 18 sales portals alongside distribution facilities across Canada and the US.
KushCo Holdings Share Price Analysis
Price is meant to change, and for KushCo Holdings, a similar scenario has been observed all along. There has been an up and down fluctuation throughout this year with the last few days the stock showing some upward trajectory once again.
The stock’s sentiments received a boost in revenues in Q1 with the company delivering a 186% year-over-year increase. Currently, the stock’s price is at $5.15 and still showing signs of an upward trajectory.
Moreover, the positive developments that the company is undertaking will only shore the stock’s sentiments; hence, soon, we might see a massive move.
Notably, during the first quarter of 2019, the key driver to the price action activity was the massive signing of the long-term supply agreement of $75 million.
KushCo Holdings Recent Developments
At first glance, the company is a pleasant surprise. And complementing firm’s outlook, the stock remains to be a real business showing growing revenue. It’s the quality that distinguishes it from other stocks that are shaky ventures built just on hype.
So, What Has the Cannabis Company Done?
KushCo has simply carved out a clear niche in wholesale distribution of the packaging supplies and customized branding products. The approach the company used is merely rolling up the other companies instead of developing the products itself.
However, the going hasn’t been smooth for KushCo, but with the recent new certified biodegradable, composite as well as sustainable packaging solution, the company’s investor confidence looks to be strengthened.
Besides, it already signed a long-term development alongside a distribution agreement with IEKO for a new packaging solution. The solution is simply designed for unique demands of the marijuana sector featuring proprietary biodegradable materials from the renewable resources.
Notably, the company acquired a private investor and entrepreneur, Danny Mosses into its advisory board. Also, CNBC’s Tim Seymour will be part of the board that is expected to provide significant insight as well as knowledge on ways of pursuing opportunities in the sector.
Currently, California is the company’s top market with its revenue growing at a faster rate in various areas. Precisely, the sales Michigan and Massachusetts are sky-high as they have both legalized adult-use recreational cannabis on top of the medical cannabis.
Understandably, the legalization of hemp in the United States will also benefit KushCo as demand will also increase its packaging products.
The recent fiscal 2019 Q2 results showed it up that the company is indeed poised for a great future. The company’s revenue soared to an all-time high of about $35.2 million. The results were up 240% year-over-year while 39% quarter over quarter.
Furthermore, the firm increased its full-year revenue outlook, although not as much profitable as GTI may be. More importantly, despite the lag in margins, the company is pushing forward with intentions and great potential.
What’s Next for KushCo Holdings
As much as the cash flow, the profitability of the firm also remains elusive; the future looks promising. Due to poor liquidity, massive dilution was also inevitable, and hence, finance is required. But with the promising results of the Q1 report, KushCo Holdings looks a stock very well worth of keeping an eye on going forward.
Consequently, despite the struggle through the tight trading range, the stock is still destined for a thrilling ride given the array of developments it continues to make.
For the latest updates on KSHB and the hottest MJ stocks, sign up below!
Disclosure: We have no position in KSHB and have not been compensated for this article.
What Do Investors See In Medical Marijuana Stock (OTCMKTS:MJNA)?
Medical Marijuana Stock (OTCMKTS:MJNA) has emerged as one of many investor’s favorite pot stocks in the legal cannabis universe in 2020. The stock is already up about 10% in 2020, demonstrating how investors have warmed up to the stock early on in the New Year.
Following a disastrous 2019, cannabis investors lost money but have also learned that their best bets are stocks with strong fundamentals. They are looking for companies that have positioned themselves well in the cannabis industry and have what it takes to go for the opportunities. That is why MJNA stock is catching a lot of investor attention in 2020 because of how it has positioned itself in the cannabis market.
Robust revenue growth and strong financial position have also helped put MJNA on the radar of investors hunting for quality cannabis stocks. Revenue at MJNA more than doubled from $26.5 million in 2017 to $60 million in 2018. MJNA is also not in financial distress as may be the case with other cannabis companies out there. The company finished the third quarter, the most recent reported period, with $5.5 million in cash reserves.
Moreover, MJNA has recently taken steps to expand into new international markets and invest in companies that are leaders in their segments. These prudent actions are helping lift Medical Marijuana stock as more investors learn about them.
About Medical Marijuana stock
Is Tilray Inc (NASDAQ:TLRY) A Buy Or Sell?
For Tilray Inc (NASDAQ:TLRY) and the rest of cannabis stocks, 2019 was no doubt a bad year. But 2020 is shaping up to be a promising year for the stock. To start with, Tilray stock has already gained 8.35% year-to-date. If that says anything, it shows following the broad selloff in Tilray stock last year, we’ve got to a point where sellers are giving way to buyers in the stock.
There are several catalysts that should continue driving NASDAQ:TLRY as you’re about to see. First, below is a brief profile of the company we’re discussing.
Tilray is a Canada-headquartered global cannabis company. It is engaged in activities of cannabis cultivation and processing as well as marketing and distribution of cannabis products. Tilray already has several cannabis products brands to its portfolio. It operates across five continents through subsidiaries in Canada, Australia, Germany, and Portugal.
Following the broad collapse of cannabis stocks in 2019, investors are looking for cannabis stocks that can make a positive impact on their portfolios in 2020. Tilray stands out as an attractive cannabis stock pick in 2020. Here are some of the exciting things about the company.
Tilray CEO sees a bright future for the cannabis industry
On January 25, Tilray CEO Brendan Kennedy spoke on Bloomberg. In that interview, Kennedy framed a rosy outlook for the…
Is Cronos Stock (TSE:CRON)(NASDAQ:CRON) A Buy?
Cronos Stock (TSE:CRON)(NASDAQ:CRON) stock fell 9.22% on January 24, marking its steepest decline so far in 2020. The stock plunge followed an important disclosure that you would only expect from a company that is trying to be straight and transparent with investors. Here’s what happened.
On January 22, after market close, Cronos made a regulatory filing detailing changes in its executive team. In that SEC filing, Cronos revealed that David Hsu and William Hilson have stepped down as its chief operating officer and chief commercial officer, respectively. Unfortunately, some investors read bad news in the executive exits and sold their shares in Cronos.
But a careful reading of the filing doesn’t seem to raise any red flags. Therefore, the big stock plunged points to investors panicking to the degree of responding to a mosquito bite with a missile.
There is no doubt that 2019 was a difficult year for cannabis stocks and Cronos Stock is no exception. But before the uncalled for reaction to Cronos’s regulatory filing, we had been at a point where sellers were starting to give way to buyers in Cronos stock. The stock has gained about 8.0% in the past one month. It had gained more than 13% year-to-date before the January 24 big selloff.
About Cronos Stock
Cronos Stock is a Canada-based global cannabis company. Cronos operates through subsidiaries and…